Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.27
-0.01-0.78%
At close: Dec 17, 4:00 PM EST
$1.40
0.1310.24%
After Hours: 6:51 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioCardia (BCDA) stock?
You can purchase shares of BioCardia (NASDAQ:BCDA) through any online brokerage.
Who are BioCardia (BCDA) competitors?
Other companies in BioCardia’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNA), Curis Inc (NASDAQ:CRIS), Cellectar Biosciences Inc (NASDAQ:CLRB), Imunon Inc (NASDAQ:IMNN) and Bolt Biotherapeutics Inc (NASDAQ:BOLT).
What is the forecast, or price target, for BioCardia (BCDA) stock?
BioCardia has a consensus price target of $25.00.
What is the current price for BioCardia (BCDA)?
The stock price for BioCardia (NASDAQ: BCDA) is $1.4 last updated December 17, 2025 at 6:51 PM EST.
Does BioCardia (BCDA) pay a dividend?
There are no upcoming dividends for BioCardia.
When is BioCardia (NASDAQ:BCDA) reporting earnings?
BioCardia does not have any upcoming earnings scheduled.
Is BioCardia (BCDA) going to split?
There is no upcoming split for BioCardia.
What sector and industry does BioCardia (BCDA) operate in?
BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
